1. Home
  2. NEPH vs ANTX Comparison

NEPH vs ANTX Comparison

Compare NEPH & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEPH
  • ANTX
  • Stock Information
  • Founded
  • NEPH 1997
  • ANTX 2017
  • Country
  • NEPH United States
  • ANTX United States
  • Employees
  • NEPH N/A
  • ANTX N/A
  • Industry
  • NEPH Medical/Dental Instruments
  • ANTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • NEPH Health Care
  • ANTX Health Care
  • Exchange
  • NEPH Nasdaq
  • ANTX Nasdaq
  • Market Cap
  • NEPH 36.1M
  • ANTX 33.2M
  • IPO Year
  • NEPH 2004
  • ANTX 2022
  • Fundamental
  • Price
  • NEPH $3.65
  • ANTX $1.09
  • Analyst Decision
  • NEPH Buy
  • ANTX Buy
  • Analyst Count
  • NEPH 1
  • ANTX 2
  • Target Price
  • NEPH $5.00
  • ANTX $2.00
  • AVG Volume (30 Days)
  • NEPH 51.5K
  • ANTX 90.6K
  • Earning Date
  • NEPH 08-07-2025
  • ANTX 08-12-2025
  • Dividend Yield
  • NEPH N/A
  • ANTX N/A
  • EPS Growth
  • NEPH N/A
  • ANTX N/A
  • EPS
  • NEPH 0.08
  • ANTX N/A
  • Revenue
  • NEPH $15,517,000.00
  • ANTX N/A
  • Revenue This Year
  • NEPH $17.06
  • ANTX N/A
  • Revenue Next Year
  • NEPH $12.20
  • ANTX N/A
  • P/E Ratio
  • NEPH $49.00
  • ANTX N/A
  • Revenue Growth
  • NEPH 10.34
  • ANTX N/A
  • 52 Week Low
  • NEPH $1.36
  • ANTX $0.87
  • 52 Week High
  • NEPH $5.00
  • ANTX $2.98
  • Technical
  • Relative Strength Index (RSI)
  • NEPH 49.52
  • ANTX 52.20
  • Support Level
  • NEPH $3.45
  • ANTX $1.05
  • Resistance Level
  • NEPH $3.81
  • ANTX $1.10
  • Average True Range (ATR)
  • NEPH 0.26
  • ANTX 0.03
  • MACD
  • NEPH -0.10
  • ANTX 0.01
  • Stochastic Oscillator
  • NEPH 24.37
  • ANTX 83.50

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

About ANTX AN2 Therapeutics Inc.

AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.

Share on Social Networks: